Fig. 4.
Fig. 4. Kinetics of intracellular cAMP changes in BL cells treated by 38.13 MoAb. CD77+ Ramos, Daudi, and MUTU I cells, and CD77− Namalwa, MUTU III, and VT500 cells were cultured with 38.13 anti-CD77 MoAb for various times, and cAMP concentrations were measured. Results are expressed in fold increase (left ordinate) of the basal cAMP level measured before stimulation (Ramos, 5.3; Daudi, 5.4; MUTU I, 2.3; Namalwa, 9; MUTU III, 3.2; VT500, 2.7 pmol/106 cells). The effect of forskolin (50 μmol/L) on cAMP concentrations (fold increase on the right ordinate) in Ramos cells is also shown. Results are representative of seven independent experiments.

Kinetics of intracellular cAMP changes in BL cells treated by 38.13 MoAb. CD77+ Ramos, Daudi, and MUTU I cells, and CD77 Namalwa, MUTU III, and VT500 cells were cultured with 38.13 anti-CD77 MoAb for various times, and cAMP concentrations were measured. Results are expressed in fold increase (left ordinate) of the basal cAMP level measured before stimulation (Ramos, 5.3; Daudi, 5.4; MUTU I, 2.3; Namalwa, 9; MUTU III, 3.2; VT500, 2.7 pmol/106 cells). The effect of forskolin (50 μmol/L) on cAMP concentrations (fold increase on the right ordinate) in Ramos cells is also shown. Results are representative of seven independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal